David Groberman is an entrepreneur and the CEO of HeraMED, a pioneering digital health company headquartered in Israel. With a strong focus on maternal and fetal health, HeraMED is dedicated to developing innovative solutions for monitoring the well-being of expectant mothers and their babies. Through cutting-edge technology and digital health advancements, HeraMED aims to revolutionize the way pregnancy is monitored, providing personalized and accessible healthcare solutions to ensure the health and safety of both mothers and their unborn children. David's leadership and passion for improving maternal and fetal health make him a driving force in the field of digital health innovation.